-
D-I03
- names:
D-I03
- CAS号:
688342-78-1
MDL Number: - MF(分子式): C23H36N6S MW(分子量): 428.64
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM004746-5mg | 5mg | ¥ 0.00 | ¥ 0.00 | Backorder | ¥ 0.00 | |||
| YZM004746-1mg | 1mg | >97% | ¥ 0.00 | ¥ 0.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | D-I03 |
| CAS号 | 688342-78-1 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C23H36N6S |
| 分子量 Molecular Weight | 428.64 |
| 溶解度Solubility | |
| 性状 | |
| 储藏条件 Storage conditions | 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description. |
| 产品说明 | |
| Introduction | D03 is a selectiveRAD52inhibitor with aKdof 25.8 μM. D03 specifically inhibitsRAD52ependent singletrand annealing (SSA) and Doop formation withIC50s of 5 μM and 8 μM, respectively. D03 suppresses growth of BRCA1and BRCA2eficient cells and inhibits formation of damagenducedRAD52foci, but does not effect on RAD51 foci induced by Cisplatin[2]. |
| Application1 | |
| Application2 | |
| Application3 |
D-I03 是一种选择性RAD52抑制剂,Kd为 25.8 μM。D-I03 抑制RAD52依赖性单链退火 (SSA) 和 D 环形成,IC50分别为 5 μM 和 8 μM。D-I03 抑制 BRCA1 和 BRCA2 缺陷细胞的生长,并抑制顺铂诱导的RAD52病灶形成,但对 RAD51 无影响。D-I03 is a selectiveRAD52inhibitor with aKdof 25.8 μM. D-I03 specifically inhibitsRAD52-dependent single-strand annealing (SSA) and D-loop formation withIC50s of 5 μM and 8 μM, respectively. D-I03 suppresses growth of BRCA1- and BRCA2-deficient cells and inhibits formation of damage-inducedRAD52foci, but does not effect on RAD51 foci induced by Cisplatin[1][2].
【1】.Huang F, et al. Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitors. Nucleic Acids Res. 2016 May 19;44(9):4189-99.
【2】.Hengel SR, et al. Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy. Cell Chem Biol. 2017 Sep 21;24(9):1101-1119.
【3】.Sullivan-Reed K, et al. Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells. Cell Rep. 2018 Jun 12;23(11):3127-3136.
【2】.Hengel SR, et al. Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy. Cell Chem Biol. 2017 Sep 21;24(9):1101-1119.
【3】.Sullivan-Reed K, et al. Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells. Cell Rep. 2018 Jun 12;23(11):3127-3136.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


